Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
The decision in the patent infringement lawsuit filed by Incyte will delay Sun's U.S. launch of Leqselvi.
read more
Axonis will use proceeds from an oversubscribed Series A financing round towards advancing its lead development candidate, an oral therapeutic for KCC2.
read more
Protega has won U.S. FDA approval for a 10 mg immediate-release version of its RoxyBond pain management tablet featuring abuse-deterrent technology.
read more
Rectify Pharmaceuticals has selected a lead positive functional modulator and is advancing to first-in-human clinical trials for primary sclerosing cholangitis.
read more
Merck has acquired Yale University spinout company Modifi Biosciences, picking up a preclinical glioblastoma asset in a deal that could reach $1.3 billion.
read more
Vaxart will present research on its phase 2 COVID and norovirus oral tablet vaccine candidates at the World Vaccine Congress Europe.
read more
Orlynvah is the first FDA-approved product for Dublin-based Iterum, and the first oral penem approved in the U.S.
read more
French government blessing in hand, Sanofi enters exclusive negotiations to sell a controlling stake in Opella in a deal worth over $16 billion...
read more
Amneal has received U.S. FDA approval for its pyridostigmine bromide extended-release tablets indicated for pretreatment against the lethal effects of soman nerve agent poisoning...
read more
OncoZenge says it plans to partner with Pharmanovia, regarding commercialization rights for its oral lozenge formulation of bupivacaine, BupiZenge, in Europe, the Middle East and Northern Africa...
read more
Madrid-based plant extract producer Natac Group has received a GMP quality certificate from the Spanish Agency of Medicines and Medical Products, allowing the company to make active ingredients for the pharma industry...
read more
Catalent has entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset, NJ to Belgium CDMO Ardena...
read more
CDMO Sirio Pharma has invested approximately $17.4 million in a dedicated packaging facility at its Pritzwalk campus near Berlin...
read more
Vanda Pharmaceuticals has received a second unsolicited, non-binding proposal from UK-based Cycle Group to acquire the company and has once again rejected the offer...
read more
Sanofi has entered into negotiations with U.S.-based private equity company CD&R for the potential sale of a 50% controlling stake in Opella, its consumer health care business...
read more